These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6997021)

  • 1. Dopaminergic modulation of aldosterone secretion is independent of alterations in renin secretion.
    Sowers JR; Tuck ML; Golub MS; Sollars EG
    Endocrinology; 1980 Oct; 107(4):937-41. PubMed ID: 6997021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat.
    Sowers JR; Golub M; Tuck M; Sowers DK
    Clin Exp Hypertens (1978); 1981; 3(1):1-14. PubMed ID: 7472089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
    Stern N; Eggena P; Chandler W; Tuck ML
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of renin release.
    Sowers JR; Barrett JD; Sambhi MP
    Clin Exp Hypertens (1978); 1981; 3(1):15-25. PubMed ID: 7009102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the renin--aldosterone axis and of prolactin secretion during pregnancy by L-dopa.
    Kaulhausen H; Oney T; Leyendecker G
    Br J Obstet Gynaecol; 1982 Jun; 89(6):483-8. PubMed ID: 7044409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evidence for an indirect mechanism mediating enhanced aldosterone secretion by metoclopramide.
    Zanella MT; Bravo EL
    Endocrinology; 1982 Nov; 111(5):1620-5. PubMed ID: 6290189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
    Sowers JR; Berg G; Martin VS; Mayes DM
    Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR; Berg G; Tuck ML; Martin VI; Chandler DW; Mayes DM
    J Clin Endocrinol Metab; 1982 Mar; 54(3):523-7. PubMed ID: 7035483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
    Rabinowe SL; Taylor T; Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
    Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
    J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral effects of dopamine on the renin-angiotensin-aldosterone system in conscious rats.
    Kondo K; Suzuki H; Handa M; Nagahama S; Yasui T; Fujimaki M; Ogihara T; Saruta T
    Jpn Circ J; 1981 Sep; 45(9):1121-5. PubMed ID: 7029031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats.
    Jungmann E; Wächtler M; Schwedes U; Usadel KH; Schöffling K
    Res Exp Med (Berl); 1983; 183(2):133-8. PubMed ID: 6361937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man.
    Whitfield L; Sowers JR; Tuck ML; Golub MS
    J Clin Endocrinol Metab; 1980 Oct; 51(4):724-9. PubMed ID: 6252224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.